The Expense Ratio

The Expense Ratio is a crucial metric used in the context of employer-sponsored 401(k) retirement plans to assess the overall cost of managing investment funds within the plan. It represents the percentage of a participant's total invested assets that are deducted annually to cover the plan's operating expenses, administrative fees, management fees, and other costs associated with maintaining the investment options.

Explanation: In an employer 401(k) plan, employees have the option to allocate a portion of their pre-tax income into various investment funds. Each fund incurs expenses for portfolio management, record-keeping, legal compliance, and other services, which are collectively known as the expense ratio. A lower expense ratio is generally desirable as it translates to reduced costs, allowing participants to retain a higher proportion of their investment returns.

Examples:

  • Company A 401(k) Plan: The Company A 401(k) plan offers its employees a selection of mutual funds to invest in for their retirement savings. One of the available funds, the Large-Cap Equity Fund, has an expense ratio of 0.75%. For every $1,000 invested in this fund, $7.50 will be deducted annually to cover expenses associated with managing the fund.
  • Index Fund Option: In some 401(k) plans, participants may have access to low-cost index funds with expense ratios as low as 0.10%. For instance, the S&P 500 Index Fund has an expense ratio of 0.12%. This means that only $1.20 will be deducted yearly for every $1,000 invested in this fund, making it an attractive option for cost-conscious investors.
  • High-cost Fund Impact: Consider a participant who invests $50,000 in a high-cost bond fund with an expense ratio of 1.50%. In this case, $750 will be deducted annually from the participant's investment, significantly impacting the overall growth potential of their retirement savings over time. Choosing lower-cost alternatives can help enhance long-term returns in a 401(k) plan.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.